Related references
Note: Only part of the references are listed.Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013
Hyeyeun Lim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Primary Thyroid Carcinoma with Low-Risk Histology and Distant Metastases: Clinicopathologic and Molecular Characteristics
Bin Xu et al.
THYROID (2017)
Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer Genetic Duet of BRAF and TERT Promoter Mutations in Thyroid Cancer Mortality
Rengyun Liu et al.
JAMA ONCOLOGY (2017)
Advances in the molecular pathogenesis of thyroid cancer: lessons from the cancer genome
Garcilaso Riesco-Eizaguirre et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma
Chen-Kai Chou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
Inigo Lancia et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Biologic and Clinical Perspectives on Thyroid Cancer
James A. Fagin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis
Xingyun Su et al.
ONCOTARGETS AND THERAPY (2016)
β-catenin signaling is required for RAS-driven thyroid cancer through PI3K activation
Ana Sastre-Perona et al.
ONCOTARGET (2016)
The miR-146b-3p/PAX8/NIS Regulatory Circuit Modulates the Differentiation Phenotype and Function of Thyroid Cells during Carcinogenesis
Garcilaso Riesco-Eizaguirre et al.
CANCER RESEARCH (2015)
MiR-146b-5p Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Thyroid Cancer by Targeting ZNRF3
Xianzhao Deng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation
Megan L. Burger et al.
BLOOD (2014)
A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears
Ambrogio Fassina et al.
CANCER CYTOPATHOLOGY (2014)
Integrated Genomic Characterization of Papillary Thyroid Carcinoma
Nishant Agrawal et al.
CELL (2014)
Correlations between the Expression Levels of Micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the Clinicopathologic Parameters in Papillary Thyroid Cancers
F. Acibucu et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2014)
Radiation-induced signaling pathways that promote cancer cell survival (Review)
Ashley L. Hein et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas
Bartosz Wojtas et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Therapeutic targeting of microRNAs: current status and future challenges
Zhonghan Li et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Deregulation of microRNA expression in thyroid neoplasias
Pierlorenzo Pallante et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
STAT3 Induction of miR-146b Forms a Feedback Loop to Inhibit the NF-κB to IL-6 Signaling Axis and STAT3-Driven Cancer Phenotypes
Michael Xiang et al.
SCIENCE SIGNALING (2014)
MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
Cesar Seigi Fuziwara et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
MicroRNA-222 and MicroRNA-146b Are Tissue and Circulating Biomarkers of Recurrent Papillary Thyroid Cancer
James C. Lee et al.
CANCER (2013)
Prognostic Implications of miR-146b Expression and Its Functional Role in Papillary Thyroid Carcinoma
Chen-Kai Chou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
FOXO1 Controls Thyroid Cell Proliferation in Response to TSH and IGF-I and Is Involved in Thyroid Tumorigenesis
Miguel A. Zaballos et al.
MOLECULAR ENDOCRINOLOGY (2013)
Comprehensive MicroRNA Expression Profiling Identifies Novel Markers in Follicular Variant of Papillary Thyroid Carcinoma
Matthias Dettmer et al.
THYROID (2013)
Molecular pathogenesis and mechanisms of thyroid cancer
Mingzhao Xing
NATURE REVIEWS CANCER (2013)
The functions and regulation of the PTEN tumour suppressor
Min Sup Song et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer
M. V. Geraldo et al.
ONCOGENE (2012)
STAT3 negatively regulates thyroid tumorigenesis
Joana Pinto Couto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Molecular genetics and diagnosis of thyroid cancer
Yuri E. Nikiforov et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
A putative role for microRNA-205 in mammary epithelial cell progenitors
Stephanie B. Greene et al.
JOURNAL OF CELL SCIENCE (2010)
Role of NF-κB in thyroid cancer
Francesco Pacifico et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
TransmiR: a transcription factor-microRNA regulation database
Juan Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid Cancer
Mingzhao Xing
THYROID (2010)
Oncogenic Kras Requires Simultaneous PI3K Signaling to Induce ERK Activation and Transform Thyroid Epithelial Cells In vivo
Kelly A. Miller et al.
CANCER RESEARCH (2009)
The BRAFV600E Oncogene Induces Transforming Growth Factor β Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer
Garcilaso Riesco-Eizaguirre et al.
CANCER RESEARCH (2009)
Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA, and AKT1
Julio C. Ricarte-Filho et al.
CANCER RESEARCH (2009)
p27 as Jekyll and Hyde Regulation of cell cycle and cell motility
Michelle D. Larrea et al.
CELL CYCLE (2009)
PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer
C. J. Guigon et al.
ONCOGENE (2009)
Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia
John E. Paes et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Phosphatidylinositol 3-Kinase/Akt and Ras/RafMitogen-Activated protein kinase pathway mutations in anaplastic thyroid cancer
Libero Santarpia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers
Zhi Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Pten loss in the mouse thyroid causes goiter and follicular adenomas:: Insights into thyroid function and Cowden disease pathogenesis
Nicole Yeager et al.
CANCER RESEARCH (2007)
NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses
Konstantin D. Taganov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Mutation of the PIK3CA gene in anaplastic thyroid cancer
G García-Rostán et al.
CANCER RESEARCH (2005)
PTEN enters the nucleus by diffusion
FH Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
P Soares et al.
ONCOGENE (2003)
Activation of Akt/protein kinase B overcomes a G2/M cell cycle checkpoint induced by DNA damage
ES Kandel et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer
G Viglietto et al.
NATURE MEDICINE (2002)
Mitomycin C induces apoptosis and caspase-8 and-9 processing through a caspase-3 and Fas-independent pathway
F Pirnia et al.
CELL DEATH AND DIFFERENTIATION (2002)
Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer
T Frisk et al.
GENES CHROMOSOMES & CANCER (2002)
PTEN expression is reduced in a subset of sporadic thyroid carcinomas:: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1
P Bruni et al.
ONCOGENE (2000)
Share Paper
